E. Meliga

Clinical Outcomes According to the Extent of Atherosclerotic Disease in Female Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the WIN‐TAVI Registry
20251 citationsauthor #18
Percutaneous Coronary Intervention for Left Main Disease in High Bleeding Risk: Outcomes from a Subanalysis of the Delta 2 Registry
20250 citationsauthor #3
PERCUTANEOUS CORONARY INTERVENTION FOR LEFT MAIN DISEASE IN HIGH BLEEDING RISK: OUTCOMES FROM A SUBANALYSIS OF THE DELTA 2 REGISTRY
20240 citationsauthor #3
Impact of Baseline Left Ventricular Ejection Fraction on Mid-term Outcomes in Women Undergoing Transcatheter Aortic Valve Implantation: Insight from the WIN TAVI Registry.
20243 citationsauthor #17
Prognostic impact of pre-frailty and frailty in women undergoing TAVR: Insights from the WIN-TAVI Registry.
20236 citationsauthor #15
Outcomes in Patients With Early Menopause Who Underwent Transcatheter Aortic Valve Implantation.
20230 citationsauthor #18
C51 INTRAVASCULAR LITHOTRIPSY FOR THE TREATMENT OF SEVERELY CALCIFIED CORONARY STENOSIS IN ACUTE MYOCARDIAL INFARCTION
20230 citationsauthor #5
TCT-232 Percutaneous Coronary Intervention for Left Main Disease in High Bleeding Risk: Outcomes From a Subanalysis of the Delta 2 Registry
20230 citationsauthor #3
“No-Reflow” Phenomenon: A Contemporary Review
202273 citationsauthor #4
Abstract 14790: Impact of Pre-Frailty and Frailty in Women Undergoing TAVR: Insights From the WIN-TAVI Registry
20221 citationsauthor #18
[The importance of intensive lipid-lowering therapy after acute coronary syndrome: changing the paradigm to improve the achievement of targets].
20223 citationsauthor #20
Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries
202212 citationsauthor #9
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry).
20229 citationsauthor #20
Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort.
20225 citationsauthor #15
Corrigendum to 'Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents'[The American Journal of Cardiology 118 (2016) 32-39].
20220 citationsauthor #13
Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy Introduction
20210 citationsauthor #18
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
202156 citationsauthor #18
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry
20215 citationsauthor #20
RENASCENT II: First in Human Evaluation of a Novel Sirolimus-Eluting Ultra-High Molecular Weight APTITUDE® Bioresorbable Scaffold: 9-and 24-Months Imaging and Clinical Results.
20205 citationsauthor #22
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry
202010 citationsauthor #22
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
20203,930 citationsauthor #18
Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing TAVI for severe aortic stenosis: Insights from the WIN‐TAVI registry
202022 citationsauthor #15
Sex-differences in outcomes after PCI or CABG for left main disease: from the DELTA registries
20201 citationsauthor #9
Questions and answers on workup diagnosis and risk stratification: a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
202021 citationsauthor #3
Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry.
20204 citationsauthor #20
First in human evaluation of a novel Sirolimus-eluting ultra-high molecular weight bioresorbable scaffold: 9-, 24-and 36-months imaging and clinical results from the multi-center RENASCENT study.
20203 citationsauthor #12
New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry.
20195 citationsauthor #7
Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).
20197 citationsauthor #14
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates.
20194 citationsauthor #14
Early P2Y12 Inhibitors Escalation in Primary PCI Patients: Insights from the RENOVAMI Registry
20180 citationsauthor #3
Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN‐TAVI registry
201830 citationsauthor #17
ASSOCIATIONS BETWEEN VALVE TYPE AND OUTCOMES IN WOMEN UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE WIN-TAVI REGISTRY
20180 citationsauthor #16
New-Generation Drug-Eluting Stents for Left Main In-Stent Restenosis: The DELTA-2 Registry.
20185 citationsauthor #6
Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).
201821 citationsauthor #19
1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
201894 citationsauthor #13
Percutaneous Closure of a Left Ventricular Pseudoaneurysm Causing Recurrent Embolization, With Cerebral Protection and Extracorporeal Membrane Oxygenation Support.
20185 citationsauthor #3
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.
201739 citationsauthor #8
IMPACT OF SINGLE VERSUS DUAL ANTI PLATELET THERAPY ON EARLY OUTCOMES IN WOMEN UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE WIN-TAVI REGISTRY
20171 citationsauthor #13
In-Hospital and 1-Year Outcomes of Rotational Atherectomy and Stent Implantation in Patients With Severely Calcified Unprotected Left Main Narrowings (from the Multicenter ROTATE Registry).
201724 citationsauthor #7
Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents.
201623 citationsauthor #13
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
201622 citationsauthor #4
Acute and 30-day Outcomes in Women After TAVR : Results From the First Women in Transcatheter Aortic Valve Implantation ( WIN-TAVI ) Real World Registry
20165 citationsauthor #14
Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
201696 citationsauthor #13
TCT-718 Predictors of vascular complications in women undergoing contemporary transcatheter aortic valve replacement: A report from the WIN-TAVI registry.
20160 citationsauthor #13
Planned versus provisional rotational atherectomy for severe calcified coronary lesions: Insights From the ROTATE multi‐center registry
201662 citationsauthor #8
Provisional vs. two-stent technique for unprotected left main coronary artery disease after ten years follow up: A propensity matched analysis.
201653 citationsauthor #13
Biolimus-Eluting StenT For de-novo coRonary artery dIsease in patiENts with Diabetes mellituS: the BESTFRIENDS multicentre registry
20161 citationsauthor #1
ROTational AThErectomy in acute coronary syndrome: early and midterm outcomes from a multicentre registry.
201651 citationsauthor #9
Rotational atherectomy in very long lesions: Results for the ROTATE registry
201642 citationsauthor #8
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial.
2016152 citationsauthor #16
In-hospital and midterm clinical outcomes of rotational atherectomy followed by stent implantation: the ROTATE multicentre registry.
201655 citationsauthor #9
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry.
201631 citationsauthor #5
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates.
2015275 citationsauthor #14
TCT-650 Efficacy of a 1-year follow-up program conducted in a tertiary care centre following percutaneous aortic valve implantation: the TAVI follow-up program
20151 citationsauthor #6
Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy).
201430 citationsauthor #30
Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry).
201415 citationsauthor #3
How should I treat severe symptomatic aortic stenosis with transcatheter aortic valve implantation in a patient with right aortic arch?
20143 citationsauthor #9
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass
201442 citationsauthor #3
Clinical outcomes following percutaneous coronary intervention with drug-eluting stents versus bare metal stents in patients on chronic hemodialysis.
201314 citationsauthor #1
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.
2013769 citationsauthor #4
Paclitaxel versus sirolimus eluting stents in diabetic patients: Does stent type and/or stent diameter matter?: Long‐term clinical outcome of 2,429‐patient multicenter registry
201318 citationsauthor #7
Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in uncertain DES candidates study.
201319 citationsauthor #13
Paclitaxel‐ and sirolimus‐eluting stents in older patients with diabetes mellitus
20138 citationsauthor #7
Retrospective multicenter observational study of the interventional management of coronary disease in the very elderly: The NINETY
201313 citationsauthor #3
The clinical outcomes on percutaneous coronary intervention for ostial and/or midshaft lesions versus distal bifurcation lesions from the DELTA registry: a multicenter registry evaluating percutaneous
20130 citationsauthor #3
THE ROLE OF FEMALE SEX IN THE CONTEMPORARY TREATMENT OF THE LEFT MAIN CORONARY ARTERY INSIGHTS FROM THE W– DELTA (WOMEN– DRUG ELUTING STENT FOR LEFT MAIN CORONARY ARTERY DISEASE) REGISTRY
20130 citationsauthor #3
Effects of EPC capture stent and CD34+ mobilization in acute myocardial infarction.
20139 citationsauthor #5
Long term clinical outcomes in DES implantation for unprotected left main disease.
20130 citationsauthor #6
Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry.
20134 citationsauthor #1
TCT-190 Biolimus Eluting StenT For de novo coRonary artery dIsease in patiENts with Diabetes mellituS: the BESTFRIENDS multicentre registry.
20130 citationsauthor #1
TCT-590 Plaque modifications after drug eluting balloon assessed by virtual histology. The PATRIOTS trial.
20130 citationsauthor #1
058 THE ROLE OF FEMALE SEX IN THE CONTEMPORARY TREATMENT OF THE LEFT MAIN CORONARY ARTERY INSIGHTS FROM THE W-DELTA (WOMEN-DRUG ELUTING STENT FOR LEFT MAIN CORONARY ARTERY DISEASE) REGISTRY
20130 citationsauthor #3
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous
201382 citationsauthor #3
TCT-388 Impact of main branch selection on clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery disease: a substudy from the DELTA registry.
20130 citationsauthor #1
Tuesday, 28 August 2012
20121 citationsauthor #4166
Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
2012137 citationsauthor #2
Percutaneous Closure of Periprosthetic Paravalvular Leak: Single Center Experience
20126 citationsauthor #5
Long-term outcomes of percutaneous coronary interventions with stent implantation in patients ≤40 years old.
201227 citationsauthor #1
New drug-eluting stent implantation for recalcitrant in-stent restenosis treated with drug-eluting stents. the Stent-in-Stent Cube (SIS³) registry.
20113 citationsauthor #1
Percutaneous coronary interventions with an endothelial progenitor cell capture stent (EPC) for high risk patients with no option for drug eluting stents: long term clinical outcomes of a single centre registry.
20116 citationsauthor #2
Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease.
201127 citationsauthor #1
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy.
2010119 citationsauthor #4
Early experience with a new approach for percutaneous intervention of totally occluded saphenous vein graft: is the flow the best thrombolytic?
20107 citationsauthor #2
Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention: Results From the Double-Blind, Prospective, Randomized Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance
2009227 citationsauthor #4
Computed tomography in total coronary occlusions (CTTO registry): radiation exposure and predictors of successful percutaneous intervention.
2009112 citationsauthor #9
Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT).
200925 citationsauthor #1
Randomized Tailoring Treatment With Tirofiban in Clopidogrel , or Both Agents Undergoing Elective Coronary Intervention : Results From Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin
20091 citationsauthor #4
Percutaneous coronary intervention or coronary artery bypass graft for unprotected left main coronary artery disease: the endless debate.
20089 citationsauthor #1
Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease
200810 citationsauthor #8
Retrograde septal approach for a challenging chronic total occlusion of the right coronary artery.
20082 citationsauthor #7
New Frontiers in Percutaneous Interventions
20080 citationsauthor #1
Acute hemodynamic changes in percutaneous transluminal septal coil embolization for hypertrophic obstructive cardiomyopathy
20080 citationsauthor #2
Clinical Outcomes After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease The DELFT ( Drug Eluting stent for LeFT main ) Registry
20080 citationsauthor #1
Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol Design
200830 citationsauthor #13
Characterization of edge effects with paclitaxel-eluting stents using serial intravascular ultrasound radiofrequency data analysis: the BETAX (BEside TAXus) Study.
200824 citationsauthor #4
Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry.
2008117 citationsauthor #3
Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The diabetes and drug eluting stent for LeFT main registry (D-DELFT).
200812 citationsauthor #1
Proof-of-concept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularisation. Rationale, protocol design and haemodynamic results.
200823 citationsauthor #1
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
2008189 citationsauthor #1
Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD.
200842 citationsauthor #5

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT